直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

GlaxoSmithKline v. Alphapharm

GlaxoSmithKline

Alphapharm

Represented GlaxoSmithKline in multiple ANDA challenges to Orange Book listed patents covering its Paxil® pharmaceutical product.

GlaxoSmithKline v. Alphapharm, 2:01-cv-01027; 2:01-cv-03364; 2:02-cv-08493, E.D. Pa., Judges Baylson, Surrick

Related Practices

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Urologix Inc. v. Prostalund AB

ACMI Circon Corp.

Aventis Behring LLC v. Bayer Corp.

Aventis Behring LLC

Nova Design Technologies Ltd. v. Children's Medical Ventures

Children's Medical Ventures; Philips

elcommerce.com, Inc. v. SAP AG

SAP AG

Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals

Avid Radiopharmaceuticals

Elan Pharmaceuticals, Inc. v. Ivax Pharmaceuticals, Inc.

Elan Pharmaceuticals, Inc.

District court grants summary judgment in favor of AstraZeneca finding invalid all asserted claims against anti-cholesterol drug Crestor®

AstraZeneca Pharmaceuticals LP

USPTO cancels all claims for Finnegan client CRS in second CBM proceeding (in favor of)

CRS Advanced Technologies

MontaVista v. Lineo

Monta Vista

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP